Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 5:37 pm Purchase | 2025-09-30 | 13G | Savara Inc. SVRA | Venrock Healthcare Capital Partners III, L.P. | 12,681,043 7.300% | 3,659,536 (+40.56%) | Filing History |
| 2025-11-14 4:33 pm Purchase | 2025-09-30 | 13G | Savara Inc. SVRA | Nantahala Capital Management, LLC | 8,775,375 5.080% | 8,775,375 (New Position) | Filing History |
| 2025-11-14 4:27 pm Unchanged | 2025-11-12 | 13D | Savara Inc. SVRA | Growth Equity Opportunities 17, LLC | 24,471,264 12.000% | 0 (Unchanged) | Filing History |
| 2025-11-14 4:04 pm Sale | 2025-09-30 | 13G | Savara Inc. SVRA | Vestal Point Capital, LP | 4,015,000 2.300% | -6,760,000 (-62.74%) | Filing History |
| 2025-11-05 6:24 pm Purchase | 2025-10-30 | 13G | Savara Inc. SVRA | Deerfield Mgmt, L.P. | 13,569,000 6.740% | 13,569,000 (New Position) | Filing History |
| 2025-10-17 6:41 pm Sale | 2025-09-30 | 13G | Savara Inc. SVRA | BlackRock Inc. BLK | 8,314,875 4.800% | -1,084,212 (-11.54%) | Filing History |
| 2025-08-14 1:12 pm Sale | 2025-06-30 | 13G | Savara Inc. SVRA | Frazier Life Sciences Public Fund, L.P. | 6,745,296 3.900% | -4,717,005 (-41.15%) | Filing History |
| 2025-07-08 5:31 pm Purchase | 2025-06-30 | 13G | Savara Inc. SVRA | Venrock Healthcare Capital Partners III, L.P. | 9,021,507 5.200% | 9,021,507 (New Position) | Filing History |
| 2025-05-15 09:52 am Purchase | 2025-03-31 | 13G | Savara Inc. SVRA | Frazier Life Sciences Public Fund, L.P. | 11,462,301 6.600% | 2,801,922 (+32.35%) | Filing History |
| 2025-03-27 5:40 pm Purchase | 2025-03-25 | 13D | Savara Inc. SVRA | Bain Capital Life Sciences Fund II, L.P. | 17,600,621 9.990% | 3,035,164 (+20.84%) | Filing History |
| 2025-02-14 2:33 pm Purchase | 2024-12-31 | 13G | Savara Inc. SVRA | Vestal Point Capital, LP | 10,775,000 6.300% | 10,775,000 (New Position) | Filing History |
| 2025-02-11 5:14 pm Purchase | 2024-12-31 | 13G | Savara Inc. SVRA | Farallon Capital Partners, L.P. | 18,288,986 9.990% | 526,453 (+2.96%) | Filing History |
| 2025-02-10 10:25 am Sale | 2024-12-31 | 13G | Savara Inc. SVRA | WELLINGTON MANAGEMENT GROUP LLP | 5,481,654 3.200% | -3,142,358 (-36.44%) | Filing History |
| 2024-11-27 11:01 am Purchase | 2024-11-20 | 13G | Savara Inc. SVRA | Frazier Life Sciences Public Fund, L.P. | 8,660,379 5.000% | 8,660,379 (New Position) | Filing History |
| 2024-11-14 5:48 pm Sale | 2024-11-14 | 13G | Savara Inc. SVRA | PRUDENTIAL FINANCIAL INC PRU | 7,410,251 4.500% | -2,378,052 (-24.29%) | Filing History |
| 2024-11-12 10:25 am Sale | 2024-09-30 | 13G | Savara Inc. SVRA | Jennison Associates LLC | 6,732,776 4.100% | -2,082,582 (-23.62%) | Filing History |
| 2024-11-12 09:37 am Purchase | 2024-09-30 | 13G | Savara Inc. SVRA | Adage Capital Management, L.P. | 6,753,701 4.100% | 6,753,701 (New Position) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Savara Inc. SVRA | BlackRock Inc. BLK | 9,399,087 5.700% | 0 (Unchanged) | Filing History |
| 2024-11-08 10:41 am Purchase | 2024-09-30 | 13G | Savara Inc. SVRA | WELLINGTON MANAGEMENT GROUP LLP | 8,624,012 5.240% | 8,624,012 (New Position) | Filing History |
| 2024-11-06 6:32 pm Purchase | 2024-09-30 | 13G | Savara Inc. SVRA | Farallon Capital Partners, L.P. | 17,762,533 9.990% | 3,435,622 (+23.98%) | Filing History |